Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Multiscale Three-Dimensional Vertical Graphene-Encapsulated Nanoparticle Coatings for Antibacterial Applications against Multidrug-Resistant Bacteria

Zhang J., Pandit S., Rahimi S., Cao Z., Mijakovic I.

Laboratory Study on Face & Skin, published in ACS Appl Nano Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
ACS Appl Nano Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41561616
PMCID
PMC12813970
DOI
10.1021/acsanm.5c05084

Abstract (original English)

Implant-associated infections caused by multidrug-resistant Staphylococcus aureus ( S. aureus ) remain a major clinical challenge, underscoring the urgent need for surface-engineered antibacterial strategies that extend beyond conventional antibiotic delivery. Here, we report a hierarchical antimicrobial coating that integrates chemical surface functionalization, nanoparticle (NP) assembly, vertical graphene (VG) growth, and antibiotic incorporation into a hybrid platform. The resulting three-dimensional composite coating (Si/APTES/NPs/VG) features a NP-mediated interfacial layer and vertically oriented graphene with a high drug-loading capacity, enabling localized, contact-mediated antibacterial activity. The Si/APTES/NPs/VG/vancomycin coating exhibited potent antibacterial efficacy, achieving a 10000-fold reduction in viable bacteria, achieving 99.99% antibacterial efficiency. Importantly, the coating also maintained favorable cytocompatibility, highlighting its potential for biomedical implant applications. Overall, this work establishes a versatile strategy for constructing carbon-based bioactive surfaces and provides a promising approach for preventing infections caused by drug-resistant S. aureus .

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research